Ebola Drug Trial Is Halted for Lack of Patients by ANDREW POLLACK

By ANDREW POLLACK

Chimerix, a pharmaceutical company, had sent enough of its antiviral drug to Liberia for 140 patients, but less than 10 had shown up, underscoring the falloff of Ebola cases in Western Africa.

Published: February 2, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1636Wn5

from WordPress http://ift.tt/1yryme2

via Hadi Aboukhater